Fmoc-R-3-amino-4-(4-tert-butylphenyl)-butyric acid, 97%, 5g

Analytical and precision scale Entris® II series Models with external adjustment, not certified, 0.001 g, 220 g, BCE223-1S (W)

(3aS,8aR)-2-(Quinolin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 1g

8-methoxyquinoline-2-carbaldehyde, 95.0%, 1g

((3-Bromophenyl)ethynyl)trimethylsilane, 95.0%, 100g

4-METHYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER, 95.0%, 100mg

6-(1-METHYL-1H-PYRAZOL-4-YL)-3-((2-METHYL-2H-INDAZOL-5-YL)THIO)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE, 95.0%, 25mg

6,7-Dihydroimidazo[1,2-a]pyridin-8(5H)-one, 95.0%, 1g

5H-Indazol-5-one, 2,4,6,7-tetrahydro-2-methyl-, 98%, 5g

Methyl 3-amino-5-fluoro-4-methylbenzoate, 95.0%, 100mg

1,1'-Bis(dicyclohexylphosphino)ferrocene>97.0%(HPLC)(T)5g

1-(5-methyl-1-propyl-1H-pyrazol-4-yl)ethanone, 95.0%, 1g

1-Benzenesulfonyl-piperidine-4-carboxylic acid amide, 1g